baber/WOPTO huggingface dataset:
Patent AT-E326198-T1 (AT)
Inventor: GREENHALGH E SKOTT
IPC: D03D1/00
Filed: 1999-08-04
Granted: 2006-06-15
Abstract: A combined stent/graft structure for repair of a body tube in a living body. The structure includes a textile graft adapted to enhance fluid integrity of the body tube and a stent expandable between a first position permitting easy insertion of the stent into the body tube and a second position wherein the stent presses securely against the inside surface of the body tube. The stent includes a first elongate wire-shaped stent member with both a stent member global axis and a stent member local axis, and is integrally secured to the graft by at least one graft yarn of which the graft is formed. Substantial portions of the first stent member global axis form a non-orthogonal angle with the graft main portion axis when projected into a plane containing the graft main portion axis. A woven textile is also part of the invention as is a method of manufacturing such a woven textile, which can be used to produce stent/graft structures according to the invention.
Patent AT-E348174-T1 (AT)
Inventor: WALLAART THORVALD EELCO
IPC: A01H5/00
Filed: 1999-08-27
Granted: 2007-01-15
Abstract: Amorpha-4,11-diene is a precursor of the new anti-malarial drug artemisinin produced by the plant Artemisia annua L.. cDNA encoding amorpha-4,11-diene synthase from A. annua has been isolated and sequenced, and the corresponding amino acid sequence has been determined. Replicable recombinant cloning vehicles are provided which code for amorpha-4,11-diene synthase or for a base sequence sufficiently complementary to at least a portion of the amorpha-4,11-diene synthase DNA or RNA to enable hybridization therewith. Modified host cells are provided that have been transformed, infected, transfected and/or injected with a recombinant cloning vehicle and/or DNA sequence encoding amorpha-4,11-diene synthase. In general terms, systems and methods are provided for the recombinant expression of amorpha-4,11-diene synthase that may be used to facilitate the production, isolation, and purification of recombinant amorpha-4,11-diene synthase or the enzyme product amorpha-4,11-diene. The subsequent use is to obtain enhanced expression of amorpha-4,11-diene synthase in an organism to accomplish enhanced morpha-4,11-diene production, either in A. annua to obtain enhanced artemisinin production, which is used as an antimalarial drug, or in another organism. <IMAGE>   <IMAGE>
Patent AT-E263539-T1 (AT)
Inventor: MUELLER INGO
IPC: A61H7/00
Filed: 1999-10-11
Granted: 2004-04-15
Abstract: A massaging apparatus (1) comprises a housing (5) having an upper wall (4) and side walls (5, 6, 7, 8) and a bottom wall (9), and massaging means (10) in the area of the bottom wall (9), which massaging means (10) are movable over a body area of a person, which massaging apparatus (1) comprises handling means (29) for holding and guiding the apparatus when the massaging means (10) are moved over a body area, which handling means comprise at least a part of the upper wall (4) of the housing (3) and, in addition, at least one strip-like handle member (30), such that a hand can be inserted at least partly between the handle member (30) and the upper wall (4) of the housing (3), the handle member (30) being preferably constructed so as to be elastic, soft, extensible in its longitudinal direction and continuously adjustable, and consists of a core (51) of a soft material and of a sleeve (52) of a material which is mild to the skin and which surrounds the core (51).
Patent AT-E218727-T1 (AT)
Inventor: ZELLNER MAXIMILIAN
IPC: G01B7/28
Filed: 1999-08-27
Granted: 2002-06-15
Abstract: A base layer, which is preferably flexible, has first conductor tracks, a first insulation layer, fine structures with first electrodes, second conductor tracks and second electrodes, and finally a second insulation layer applied to it in succession. The first electrodes are connected, via plated-through holes, to associated first conductor tracks. Changes, caused by lines in the skin of a finger pad, in the stray capacitance between adjacent first and second electrodes are evaluated for recording fingerprints.
Patent AT-E378045-T1 (AT)
Inventor: ELYAKOV GEORGY BORISOVICH
IPC: A61K9/08
Filed: 1999-07-21
Granted: 2007-11-15
Abstract: A pharmaceutical composition is provided, which comprises an aqeous solution containing a mixture of di- and tri-sodium salts of echinochrome in an amount of 0.90 to 1.10 g/ml (Histochrome). It meets the requirements that apply to injectable formulations. Administration of Histochrome reduces by 57% the necrosis zone in patients with acute myocardial infarction, restores the contractility of the left ventricle, reduces the incidence of reperfusion-induced ventricular arrhythmias and exerts an antiarrhythmogenic effect. Histochrome suppresses the aggregation of erythrocytes and thrombocytes, produces a beneficial effect on the clinical course of the disease, reduces the incidence of complications and lethal outcomes in cases of acute myocardial infarction. It is well tolerated by patients.
Patent AT-E302005-T1 (AT)
Inventor: KO SOO S
IPC: A61K31/40
Filed: 1999-12-17
Granted: 2005-09-15
Abstract: The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
Patent AT-E247592-T1 (AT)
Inventor: MYLAEUS ULRICH
IPC: B65H15/00
Filed: 1999-12-13
Granted: 2003-09-15
Abstract: The invention relates to a device for turning sheets. A sheet to be turned is guided into a gap between two transport elements moving in opposite directions and is pressed against the reverse-moving transport element or the forward-moving transport element depending on whether or not said sheet should be turned. The following transport elements then guide the turned or unturned sheet to the output of the device. The device preferably is configured such that the same transport time is required for turned and unturned sheets so that the order of the sheets and the interval between the sheets upstream and downstream of the turning device remain the same.
Patent AT-E248157-T1 (AT)
Inventor: STEIN BERND M
IPC: A61K31/37
Filed: 1999-12-30
Granted: 2003-09-15
Abstract: Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having structure I, as well as pharmaceutical compositions containing the same: wherein R1, R2, R3, n and p are as defined here.  Methods are also disclosed for modulating ER in cells and/or tissues expressing the same, such as bone, breast, prostate, uterus, CNS or the cardiovascular system. Methods for treating estrogen-related conditions are also disclosed, including conditions such as is breast cancer, osteoporosis, endometriosis, cardiovascular disease, hypercholesterolemia, prostatic hypertrophy, prostatic carcinomas, obesity, hot flashes, skin effects, mood swings, memory loss, and adverse reproductive effects associated with exposure to environmental chemicals or natural hormonal imbalances.
Patent AT-E238313-T1 (AT)
Inventor: WEINMANN WOLFGANG
IPC: A47L9/28
Filed: 1999-12-22
Granted: 2003-05-15
Abstract: The invention relates to novel cyclic siloxane compounds of the following general formula (I):in which:n=0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 preferably 1, 2, 3, 4, 5;A=H or C1-C15 alk(en)yl, C3-C15 cycloalk(en)yl, C6-C12 aryl, C8-C18 alkaryl, where, in the said radicals, in each case one or more C atoms can be replaced by O, C=O, O(C=O), SiR2 and/or NR, R being an aliphatic radical with 1 to 7 C atoms, in which one or more C atoms can be replaced by O, C=O, and/or O(C=O);B=E or a linear, branched or polycyclic aliphatic- or aromatic-groups-containing hydrocarbon radical which links 2 to 10 of the cyclosiloxane radicals defined above, less B, to one another and contains 2 to 50 C atoms and additionally 0 to 30 other atoms from the group O, N, S, P, Si, Cl, F, Br, I and from which correspondingly 1 to 9, preferably 1 to 4 of the above defined cyclosiloxane radicals, less B, are pending;E=A or a polymerizable group G-Q-L, where on average up to 50% or less of the groups E correspond to representatives of A;G=C1-10 alk(en)ylene;Q=O, N-A or a di- or polyvalent linear, branched or cyclic alcohol, amine or aminoalcohol radical with 2 to 10 C atoms;L=an organic radical, containing a C=C double bond, with 2 to 10 C atoms;and with the proviso that no annelated siloxane ring systems can occur in (I),and also dental compositions which contain the compounds of formula (I) and/or compounds of formula (II):in which:T=independently of each other H or C1-C10 alk(en)yl, C3-C10 cycloalk(en)yl, C6-C12 aryl or C8-C8 alkaryl;N=a polymerizable group R1-R2-R3;b=0 to 500, where the proportion b may be at most 50% of the repeat units (b+c);c=1 to 1000;R1=C1-C10 alk(en)ylene;R2=O, N-T or a di- or polyvalent linear, branched or cyclic alcohol, amine or aminoalcohol radical with 2 to 10 C atoms;R3=an organic radical, containing a C=C double bond, with 3 to 10 C atoms;V=SiMe2T, SiEt2T, SiMePhT, SiPh2T.
Patent DE-04778235-T1 (DE)
Title: Unterwasser-luft/mischgas-auslasssystem
Inventor: SCHULTZ M
IPC: B63C11/02
Filed: 2004-07-12
Abstract: Ein
Unterwasser-Auslass-System, umfassend:  ein Luftreglergehäuse;  mindestens
ein Auslassventil wirkend verbunden mit dem Luftreglergehäuse, wobei
das mindestens eine Auslassventil eine Wasser-Grenzflächenwand
mit einer unteren Dichtkante und einer oberen Dichtkante aufweist;  mindestens
einen Blasenabweiser, der mit dem Luftreglergehäuse verbunden ist und einen
Lufttaschenraum definiert, der mit der Wasser-Grenzflächenwand
des mindestens einen Auslassventils in Kontakt steht;  und  mindestens
eine Wassereinlass-Passage, die in dem mindestens einen Blasenabweiser
unterhalb der unteren Dichtkante des mindestens einen Auslassventils
ausgebildet wird, um eine freie Flüssigkeitsströmung innerhalb
des Luftreglers zu verhindern.
Patent DE-10191273-T1 (DE)
Inventor: GILSON PAUL
IPC: A61B17/22
Filed: 2001-04-20
Abstract: An embolic protection system 1 comprises a guidewire 99 for advancing through a vasculature, the guidewire 99 having a distal end and a proximal end; an embolic protection filter 1 having a filter body 41 with a distal end and a proximal end, the filter body 41 providing for a collapsed configuration and an expanded deployed configuration. The embolic protection filter body 41 has a guidewire path for slidably receiving the guidewire 99 to permit movement of the filter 1 relative to the guidewire 99 when the filter 1 is in the collapsed configuration and the expanded deployed configuration. A delivery catheter 2 is advanceable over the guidewire 99 for delivery of the embolic protection filter 1; the delivery catheter 2 having a a proximal end and a distal end. The filter 1 is deployed from the distal end of the delivery catheter 2 into the expanded deployed configuration. A retrieval catheter 3 is also advancable over the guidewire 99 for retrieval of the filter 1, the retrieval catheter 3 having a distal end and a proximal end; and engagement elements for engaging the embolic protection filter 1 with the guidewire 99 for retrieval of the filter 1 into the retrieval catheter 3 in the collapsed configuration.
Patent DE-161824-T1 (DE)
IPC: B60W10/06
Filed: 1985-04-18
Abstract: An infinitely variable transmission has a primary pulley (24) having a hydraulically shiftable disc (24a) and a hydraulic cylinder (22) for operating the disc, and a secondary pulley (25) having a hydraulically shiftable disc (25a) and a hydraulic cylinder (28) for operating that disc. A belt (26) engages with both pulleys. A hydraulic circuit has a transmission ratio control valve (44) for controlling shifting of the disc of the primary pulley (24) in either the downshift or upshift direction. The . transmission ratio control valve (44) is operated to shift the disc (24a) of the primary pulley (24) in the downshift direction, when a throttle valve of an engine is opened rapidly when the vehicle accelerates, by a control unit 56 which receives input from a throttle position sensor (54) and operates a solenoid valve (51) connected to operate control valve (44).
Patent DE-181306-T1 (DE)
IPC: H01R24/46
Filed: 1985-11-05
Abstract: The present invention is directed to connector apparatus comprising a jack (20) usable with either a conventional plug (400) terminating a coaxial cable (410) or a special plug (200) terminating a shielded, twisted pair cable (202). Such versatility was made possible by a full body first conductor (68) having spring contactors (130) which may be separated from grounding contact with barrel (36) of housing (32) by an insulator (216) of plug (200) includes a protruding insulator (216) for separating the contactors (130) and functioning the switching mechanism. Plug (200) also includes first and second conductors (212) and (214) for connection with second and first jack conductors (76) and (68), respectively. In addition, unique structures for pieceparts and assembly details resulting in various interlocking arrangements are disclosed with respect to the structure of jack (20) and plug (200).
Patent DE-411598-T1 (DE)
IPC: B27N1/02
Filed: 1990-08-01
Abstract: This procedure refers to the incorporation of granules of cork or similar substances into polyurethane products. The polyurethane components and the cork (or similar) granules are introduced simultaneously into a suitable mixing chamber (26), the granules being suitably dosed by variable speed programmable screw conveyors (or otherwise, for example pneumatic feeds, mechanical pistons, etc.). The conglomerate as above is introduced, while still in the early stages of reaction, into fixed or moveable moulds (40) or dies by gravity (with the mould open), or by injection (with the mould closed), and completes its reaction there, forming the product in times which vary according to the characteristics of the mixture used and the shape of the article produced. The moulds or dies are preferably kept at a temperature of about 50 DEG C, though this is not critical since this factor also varies widely according to the polyurethanes used and the pieces being produced.
Patent DE-478110-T1 (DE)
Inventor: WHITE STEVEN ANDREW CARL
IPC: C09K3/10
Filed: 1991-06-05
Abstract: The sealing gasket in a beer bottle is formed of a thermoplastic composition that is a homogeneous blend of 20 to 60% by weight butyl rubber and 40 to 80% by weight other thermoplastic polymer. The use of the defined gasket prevents the ingress of volatile odours from the surrounding packaging, allows venting at high pressures and provides a good barrier to oxygen, thereby leading to good storage stability of the beer.
Patent DE-530686-T1 (DE)
Inventor: JAEAESKELAEINEN VESA
IPC: B60P3/035
Filed: 1992-08-27
Abstract: A carriage for displacing a cylindrical body into a winding machine, comprising two support elements (9) defining therebetween a space for receiving the body (2) and being adjustable with respect to each other in a transverse direction of the elements; fixed support plates (10) attached to the support elements for supporting the body; and a machinery for lifting and lowering the support means. To measure the size of the body and to be able to adjust the winding machine in advance, the carriage comprises sensors (15, 18) for measuring the width and diameter of the body while the body is supported by the support plates; and a transmitter (24) for transmitting the measuring results to the winding machine. <IMAGE>
Patent DE-685175-T1 (DE)
Inventor: DAVIS MICHAEL
IPC: A41D27/10
Filed: 1995-06-01
Abstract: A garment (20) suited for a young child comprises cuffs (30) which are devoid of any hem at their distal end and which have hidden side seams. A pouch (32) overlays the cuff at the distal end. The pouch is invertible over the cuff end to enclose an appendage such as a hand or foot of the wearer within the cuff. When the pouch is not inverted, the cuff may be turned back to expose the appendage. <IMAGE>
Patent ES-2166743-T1 (ES)
Inventor: LEHOUX JANNICK
IPC: A01N25/00
Filed: 2001-07-02
Abstract: A process for the elimination of insects and arachnids, especially acarids, comprises diffusing a solution of permethrin and tetramethrin, optionally with piperonyl butoxide, in a combustible solvent using a catalytic combustion means. The diffusion is affected using an apparatus as shown in the drawing. Solution (4) of permethrin and tetramethrin in a combustible solvent diffuses up wick (8) to a catalytic combustion means (14).
Patent ES-2087047-T1 (ES)
Inventor: SEGRESTIN PIERRE
IPC: E02D17/18
Filed: 1994-06-24
Abstract: An earth structure comprises a plurality of elongate stabilising elements (3) in an earth mass behind a facing made up of facing panels (1), and a plurality of connectors (2) behind the facing and connecting it to the stabilising elements (3). Each connector (2) has a rear attachment portion (8) attached to a respective stabilising element (3) and at least two spaced apart front attachment portions (6) attached to the facing. The earth mass comprises a first region (20) of soil suitable for plant growth, in which first region (20) the connectors (2) are located, and a second region (21) of structural backfill, in which second region (21) the stabilising elements (3) are located. <IMAGE>
Patent CY-1108012-T1 (CY)
Title: Εγχεομενες στερεες ραβδοι και παστες φωσφορικου ασβεστιου για απελευθερωση οστεογονικων πρωτεϊνων
Inventor: LI REBECCA
IPC: A61L27/50
Filed: 2007-05-08
Abstract: Οστεογονικές πρωτεΐνες απελευθερώνονται μέσω μιας εγχεόμενης στερεάς ράβδου ή σκληραινόμενης πάστας. Η συνταγοποιηση περιλαμβάνει υλικό φωσφορικού ασβεστίου, οστεογονική πρωτεΐνη και προαιρετικά πρόσθετα και δραστικά συστατικά, όπως αναστολέα επαναρρόφησης οστού. Αποκαλύπτονται επίσης μέθοδοι κατασκευής εγχεόμενων φαρμακευτικών συνθέσεων και μέθοδοι χρήσης των οστεογονικών συνθέσεων για να θεραπεύονται ελαττώματα οστού.
Patent CY-1107400-T1 (CY)
Inventor: DOWN BRIAN
IPC: A61P25/06
Filed: 2008-04-17
Abstract: The present invention relates to oral granules of montelukast sodium.
Patent CY-1110576-T1 (CY)
Inventor: KOVERECH ALEARDO
IPC: A61P43/00
Filed: 2009-03-31
Abstract: The use of acetyl L-carnitine or one of its pharmaceutically acceptable salts is described for the preparation of a medicament and/or dietetic product for the treatment of fibromyalgic syndrome.
Patent CY-1109678-T1 (CY)
Inventor: MAJKA ZBIGNIEW
IPC: C07D277/42
Filed: 2009-12-30
Abstract: The invention relates to a method of treatment and/or prophylaxis of diseases and conditions mediated by peroxysome proliferator-activated receptor gamma (PPARgamma) in a mammal subject in need thereof, said method comprising administration to said mammal a compound of formula (I) or a pharmaceutically acceptable salt thereof in a therapeutically or prophylactically effective amount wherein in formula (I) W represents a COOH group or its bioisosters, or COO-C1-C4-alkyl group; Y represents NH or N-C1-C10-alkyl; Z represents NH, N-C1-C10-alkyl, N-aryl, N-heteroaryl, S, or O; X represents O, S, NH, N-C1-C10-alkyl, N-aryl, NSO2-C1-C10-alkyl, N-SO2-aryl, or N S02-heteroaryl; R1 to R6 each independently represents a hydrogen atom or a substituent defined in the description; A is as defined in the description; n represents an integer from 0 to 4, inclusive. The compounds of formula (I) are the ligands of PPAR-gamma receptor.
Patent CY-1111193-T1 (CY)
Inventor: SHITARA KENYA
IPC: G01N33/68
Filed: 2011-02-14
Abstract: A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.
Patent CY-1113102-T1 (CY)
Title: Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
Inventor: ZHOU XIAOMING
IPC: C07D401/06
Filed: 2012-09-10
Abstract: Η εφεύρεση αφορά ενώσεις φαινυλπροπιοναμιδίου Τύπου (I):
Patent CY-1113454-T1 (CY)
Title: Παραγωγα n3 αλκυλιωμενου βενζιμιδαζολιου ως anαστολεις μεκ
Inventor: WALLACE ELI M
IPC: C07D235/04
Filed: 2012-12-04
Abstract: 6-(4-Βρωμο-2-χλωρο-φαινυλαιμινο)-7-φθορο-3-μεθυλ-3Η-βενζοϊμιδαζολο-5-καρβοξυλικού οξέος (2-υδροξυ-αιθόξυ)-αμίδιο ή φαρμακευτικές συνθέσεις αυτού για χρήση στην αναστολή μη κανονικής ανάπτυξης κυττάρου.
Patent CY-1115000-T1 (CY)
Title: Ανθρωπινα αντισωματα εναντια στη λυσσα και χρησεις αυτων
Inventor: THOMAS WILLIAM D JR
IPC: C12N5/10
Filed: 2014-03-24
Abstract: Παρέχονται στην παρούσα, ανθρώπινα μονόκλωνα αντισώματα που δεσμεύονται ειδικά στον ιό της λύσσας, τμήματα δέσμευσης αντιγόνου αυτών, και μέθοδοι δημιουργίας και χρήσεως τέτοιων αντισωμάτων και τμημάτων δέσμευσης αντιγόνου αυτών για την θεραπεία του ιού της λύσσας σε ένα υποκείμενο.
Patent CY-1117445-T1 (CY)
Title: Παραγωγα φωσφοραμιδικου της 5-φθορο-2´-δεοξυουριδινης για χρηση στην θεραπεια καρκινου
Inventor: MCGUIGAN CHRISTOPHER
IPC: C07H19/10
Filed: 2016-04-27
Abstract: Αποκαλύπτονται παράγωγα φωσφοραμιδικού της 5-φθορο-2'-δεοξυουριδίνης για χρήση στην θεραπεία καρκίνου, ειδικά στην θεραπεία καρκίνου όπου ο ασθενής παρουσιάζει αντοχή, για παράδειγμα, σε έναν ασθενή με κύτταρα με μειωμένο επίπεδο πρωτεϊνών μεταφορέα νουκλεοσιδίου ή/και με ανεπαρκή σε κινάση νουκλεοσιδίου κύτταρα ή/και με μολυνθέντα με μυκόπλασμα κύτταρα ή/και με κύτταρα με αυξημένο επίπεδο θυμιδυλικής συνθάσης.
Patent CY-1119566-T1 (CY)
Title: Αντιϊικες ενωσεις rsv
Inventor: TAHRI ABDELLAH
IPC: C07D519/00
Filed: 2017-09-13
Abstract: Αναστολείς της αντιγραφής του RSV τύπου RI που περιλαμβάνουν στερεοχημικώς ισομερείς μορφές και άλατα ή διαλυτώματα αυτών, όπου τα R22, W, Q, V, Ζ, p, s και Het έχουν την έννοια όπως ορίζεται στο παρόν. Η παρούσα εφεύρεση αναφέρεται, επίσης, σε μεθόδους για την παρασκευή των εν λόγω ενώσεων, σε φαρμακευτικές συνθέσεις που τις περιέχουν και στη χρήση τους, μεμονωμένα ή σε συνδυασμό με άλλους αναστολείς RSV, σε θεραπεία με RSV.
Patent CY-1120606-T1 (CY)
Title: Μπουνυαϊοι με προδρομα γονιδια κατακερματισμενης πρωτεϊνης και μεθοδοι δημιουργιας αυτων των ιων
Inventor: KORTEKAAS JEROEN ALEXANDER
IPC: C12N7/00
Filed: 2018-05-11
Abstract: Η εφεύρεση σχετίζεται με έναν μπουνυαϊό, στον οποίο διαχωρισμένες είναι λειτουργικά παρούσες κωδικοποιητικές περιοχές (NSm)Gn και Gc σε δύο διαφορετικά γενωμικά τμήματα, κατά προτίμηση ένας μπουνυαϊός που αποτελείται από ένα σύνολο τουλάχιστον 4 γενωμικών τμημάτων. Η εφεύρεση περαιτέρω σχετίζεται με μεθόδους παραγωγής του εν λόγω μπουνυαϊού και με μία σύνθεση που αποτελείται από τον εν λόγω μπουνυαϊό και ένα κατάλληλο έκδοχο.
Patent CY-1121172-T1 (CY)
Title: Μεθοδος για την αποκωδικοποιηση βιντεο λαμβανοντας υποψη τη σειρα σαρωσης των μοναδων κωδικοποιησης που εχουν ιεραρχικη δομη
Inventor: JUNG HAE-KYUNG
IPC: H04N19/52
Filed: 2019-01-24
Abstract: Παρέχεται μια μέθοδος και συσκευή για την αποκωδικοποίηση ενός βίντεο και μια μέθοδος και συσκευή για την κωδικοποίηση ενός βίντεο. Η μέθοδος για την αποκωδικοποίηση του βίντεο περιλαμβάνει τα ακόλουθα: λήψη και ανάλυση ενός bitstream ενός κωδικοποιημένου βίντεο, και αποκωδικοποίηση κωδικοποιημένων δεδομένων εικόνας για μέγιστη μονάδα κωδικοποίησης με βάση πληροφορίες σχετικά με κωδικοποιημένο βάθος και κωδικοποιημένη κατάσταση λειτουργίας για τη μέγιστη μονάδα κωδικοποίησης, λαμβάνοντας υπόψη μια σειρά σάρωσης ράστερ για τη μέγιστη μονάδα κωδικοποίησης και μια σειρά σάρωσης ζιγκ-ζαγκ για τις μονάδες κωδικοποίησης της μέγιστης μονάδας κωδικοποίησης σύμφωνα με τα βάθη.